Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012;30:2212–9.

Article  CAS  PubMed  Google Scholar 

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015;386:1546–55.

Article  PubMed  Google Scholar 

Ozakyol A. Global epidemiology of Hepatocellular Carcinoma (HCC Epidemiology). J Gastrointest Cancer 2017;48:238–40.

Article  PubMed  Google Scholar 

Chu CM, Liaw YF. HBsAg seroclearance in Asian patients: too high and too bad in Hong Kong. Gastroenterology 2009;136:1459–60. 1460-1.

Article  PubMed  Google Scholar 

Yip TC, Wong GL, Chan HL, Tse YK, Lam KL, Lui GC, et al. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues. J Hepatol. 2019;70:361–70.

Article  CAS  PubMed  Google Scholar 

Moucari R, Korevaar A, Lada O, Martinot-Peignoux M, Boyer N, Mackiewicz V, et al. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study. J Hepatol. 2009;50:1084–92.

Article  CAS  PubMed  Google Scholar 

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167–85.

Alawad AS, Auh S, Suarez D, Ghany MG. Durability of spontaneous and treatment-related loss of Hepatitis B s antigen. Clin Gastroenterol H 2020;18:700–9.

Article  CAS  Google Scholar 

Marcellin P, Wong DK, Sievert W, Buggisch P, Petersen J, Flisiak R, et al. Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection. Liver Int. 2019;39:1868–75.

Article  CAS  PubMed  Google Scholar 

Marcellin P, Buti M, Krastev Z, de Man RA, Zeuzem S, Lou L, et al. Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate. J Hepatol. 2014;61:1228–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu C, Sun Y, Xu L, Zhang X, Liu K, Jin J, et al. Hepatitis B seropositive status in recipients or donors is not related to worse outcomes after haploidentical hematopoietic stem cell transplantation. Transpl Cell Ther 2021;27:661–8.

Article  Google Scholar 

Buzo BF, Ramos JF, Marques Rossetti RA, Salles N, Mendrone Júnior A, Rocha V, et al. Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center. Transpl Infect Dis. 2020;22:e13243.

Francisci D, Aversa F, Coricelli V, Carotti A, Canovari B, Falcinelli F, et al. Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. Haematologica. 2006;91:980–2.

PubMed  Google Scholar 

Park S, Kim K, Kim DH, Jang JH, Kim SJ, Kim WS, et al. Changes of hepatitis B virus serologic status after allogeneic hematopoietic stem cell transplantation and impact of donor immunity on hepatitis B virus. Biol Blood Marrow Transpl. 2011;17:1630–7.

Article  Google Scholar 

Lau GK, Lok AS, Liang RH, Lai CL, Chiu EK, Lau YL, et al. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 1997;25:1497–501.

Article  CAS  PubMed  Google Scholar 

Chang YJ, Huang XJ. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review. Clin Transpl. 2011;25:13–23.

Article  CAS  Google Scholar 

Wang Y, Liu DH, Liu KY, Xu LP, Zhang XH, Han W, et al. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer-Am Cancer Soc. 2013;119:978–85.

Google Scholar 

Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transpl. 2006;38:291–7.

Article  Google Scholar 

Yan CH, Xu LP, Wang FR, Chen H, Han W, Wang Y, et al. Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transpl. 2016;51:391–7.

Article  CAS  Google Scholar 

Lok AS, Zoulim F, Dusheiko G, Chan HLY, Buti M, Ghany MG, et al. Durability of Hepatitis B surface antigen loss with nucleotide analogue and peginterferon therapy in patients with chronic Hepatitis B. Hepatol Commun 2020;4:8–20.

Article  CAS  PubMed  Google Scholar 

Li M, Zhang L, Lu Y, Chen Q, Lu H, Sun F, et al. Early serum HBsAg kinetics as predictor of HBsAg loss in patients with HBeAg-negative chronic Hepatitis B after treatment with Pegylated Interferonα-2a. Virol Sin. 2021;36:311–20.

Article  PubMed  Google Scholar 

Terrault NA, Lok ASF, McMahon BJ, Chang K, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;67:1560–99.

Article  PubMed  Google Scholar 

Yang Y, Huang A, Zhao Y. Spontaneous loss of chronic HBV infection markers in treatment-naïve children: a systematic review and pooled meta-analyses. Expert Rev Anti-Infe. 2021;19:649–60.

Article  CAS  Google Scholar 

Cao Z, Li Z, Wang Y, Liu Y, Mo R, Ren P, et al. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection. J Viral Hepat. 2017;24(Suppl 1):57–65.

Article  CAS  PubMed  Google Scholar 

Shi Y, Zheng M. Hepatitis B virus persistence and reactivation. BMJ. 2020;370:m2200.

Article  PubMed  Google Scholar 

Hui CK, Lie A, Au WY, Leung YH, Ma SY, Cheung WW, et al. A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood 2005;106:464–9.

Article  CAS  PubMed  Google Scholar 

Wu Y, Shi J, Tan Y, Zhao Y, Yu J, Lai X, et al. A novel strategy for the prevention of Hepatitis B virus-related hepatitis following allogeneic hematopoietic stem cell transplantation from Hepatitis B surface antigen-positive donors. Biol Blood Marrow Transpl. 2020;26:1719–28.

Article  CAS  Google Scholar 

Sullivan LM, Massaro JM, D’Agostino RS. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med. 2004;23:1631–60.

Article  PubMed  Google Scholar 

Ren X, Huang Q, Qu Q, Cai X, Fu H, Mo X, et al. Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation. Blood Adv. 2021;5:4910–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng RX, Wu YJ, Xu LP, Liu KY, Huang XJ, Zhang XH. Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients with hematological malignancies. Am J Hematol. 2021;96:1407–19.

Article  CAS  PubMed  Google Scholar 

Gui RY, Huang QS, Cai X, Wu J, Liu HX, Liu Y, et al. Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data. Br J Haematol. 2020;191:269–81.

Article  CAS  PubMed  Google Scholar 

Pabinger I, van Es N, Heinze G, Posch F, Riedl J, Reitter EM, et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. Lancet Haematol 2018;5:e289–98.

Article  PubMed  PubMed Central  Google Scholar 

Wu YJ, Hou M, Liu HX, Peng J, Ma LM, Yang LH, et al. A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data. Blood Adv. 2020;4:5846–57.

Article  PubMed  PubMed Central  Google Scholar 

Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26:565–74.

Article  PubMed  PubMed Central  Google Scholar 

Vickers AJ, van Calster B, Steyerberg EW. A simple, step-by-step guide to interpreting decision curve analysis. Diagn Progn Res 2019;3:18.

Article  PubMed  PubMed Central  Google Scholar 

Lavezzi M, Donati A, Davi D, Carpanelli MC, Farinelli S, Soracco E. [Response to vaccination against the etiologic agent of viral hepatitis B (HBV) in a population at risk]. Quad Sclavo Diagn. 1987;23:164–8.

CAS  PubMed  Google Scholar 

McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009;49(5 Suppl):S45–55.

Article  CAS  PubMed  Google Scholar 

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–88.

Liu JH, Liao XW, Chen CH, Yao M, Li CC, Lin CT, et al. Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world’s largest retrospective cohort study. Brit J Haematol. 2019;186:72–85.

Article  CAS  Google Scholar 

Mikulska M, Nicolini L, Signori A, Rivoli G, Del BV, Raiola AM, et al. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. Clin Microbiol Infect. 2014;20:O694–701.

Article  CAS  PubMed  Google Scholar 

Marcellin P, Ahn SH, Ma X, Caruntu FA, Tak WY, Elkashab M, et al. Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a increases loss of Hepatitis B surface antigen in patients with chronic hepatitis B. Gastroenterology 2016;150:134–44.